28 December 2010
Acute myopia and angle closure glaucoma associated with topiramate use: A case series
AliReza Dehghani, Leila Rezaei, AliReza PeymanDOI: 10.12659/AJCR.881366
Am J Case Rep 2010; 11:241-243
Abstract
Abstract
Background: To report 7 cases of topiramate-induced angle closure glaucoma.
Case Report: We present 7 cases of angle closure glaucoma after topiramate administration for neuropsychological disorders. All patients were female. The average age of patients was 33.28 years (ranging from 19 to 44 years). The mean interval between drug administration and symptoms onset was 12.2 days (ranging from 4 to 30 days).The mean best corrected visual acuity was 3 meters counting fingers in both eyes. The mean refractive errors was –6.50 diopters (ranging from –3.00 to –12.00 diopters). The mean intraocular pressure was 44.71 mmHg (ranging from 34 to 60 mmHg). The mean normalization time of intraocular pressure was 12.30 hours (ranging from 8 to 23 hours).
Conclusions: Acute myopia and acute angle closure glaucoma are serious adverse effects of topiramate use, both of which are reversible with immediate discontinuation of the drug. Thus, obtaining the drug history of the patients is critical in evaluation of angle closure glaucoma.
Keywords: Topiramat, angle closure, Glaucoma
879 10
In Press
05 Dec 2023 : Case report
Am J Case Rep In Press; DOI:
01 Dec 2023 : Case report
Am J Case Rep In Press; DOI:
01 Dec 2023 : Case report
Am J Case Rep In Press; DOI:
01 Dec 2023 : Case report
Am J Case Rep In Press; DOI:
Most Viewed Current Articles
06 Dec 2021 : Case report
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
07 Dec 2021 : Case report
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
19 Jul 2022 : Case report
DOI :10.12659/AJCR.936128
Am J Case Rep 2022; 23:e936128
13 Jul 2022 : Case report
DOI :10.12659/AJCR.936441
Am J Case Rep 2022; 23:e936441